Geriatrics
2023 Activity indicators
- 1 competitive European project: So-NUTS (ERA-Net "HDHL-INTIMIC of the JPI- HDHL)
- 3 intramural projects FIBIOHRC-IRYCIS-UAH
- 1 private project led
- 6 clinical studies led
- 26 publications
- IF: 128.30
- Q1 publications: 11 (42%)
- D1 publications: 5 (19%)
- Project evaluators: 1 PI
- Members of editorial committees: 6 researchers
- 2 consensus document (ESPEN & EASO; EuGMS)
- 1 clinical guideline
- 1 visitor received and +3 months stay:
- INCLIVA Health Research Institute
- 1 month stay in foreign centres:
- Amsterdam University (Netherlands)
Milestones
- FLeadership of the international consortium "Global Leadership Initiative in Sarcopenia" (GLIS) working on the development of the first global definition of sarcopenia.
- Increase in the number of studies within the service at the initiative of the group members and increased participation in editorial committees of scientific journals.
- First publications derived from the European project SO-NUTS - Preventing obesity, sarcopenia, and Sarcopenic Obesity in retirement - digital personalized interventions for healthy nutrition and physical activity for Seniors. (ERA-Net HDHL-PREPHOBES). PMID: 37256475 & 36882046.
- High impact and visibility of the publication: "Cruz et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 3. Eur Geriatr Med. 2023 Aug;14(4):625-632. doi: 10.1007/s41999-023-00777-y. PMID: 37256475" with an Altmetrics index of 279 (top 1% of articles of the same age, version 1 & 2)
- This is one of the groups with the highest female participation in the IRYCIS.
Bibliometrics
Articles | Accum. IF | Mean IF | Articles Q1 or Q2 | % in Q1 or Q2 | Articles D1 | % in D1 | |
---|---|---|---|---|---|---|---|
2019 | 43 | 199.53 | 4.64 | 30 | 70 | 13 | 30 |
2020 | 26 | 87.94 | 3.38 | 15 | 58 | 3 | 12 |
2021 | 29 | 114.84 | 3.96 | 14 | 48 | 2 | 7 |
2022 | 43 | 408.882 | 9.51 | 18 | 42 | 6 | 14 |
2023 | 26 | 128.30 | 4.93 | 14 | 54 | 5 | 19 |
167 | 939.49 | 5.29 | 91 | 54 | 29 | 17 |
* Only original articles, editorials, guidelines and reviews